ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2089

Social Listening Analysis of IgG4-Related Disease Social Media Discussions

Esteban Rivera1, Kelly Gavigan2, Daniel Hernandez3, Maria Picone4, Angeni Cordova4, Lauren Dougherty4, Kristina Davidson5, Brian LaMoreaux6, Anthony Amatucci7 and W. Benjamin Nowell8, 1Global Healthy Living Foundation, Long Island City, NY, 2Global Healthy Living Foundation, Upper Nyack, NY, 3Global Healthy Living Foundation, St. Johns, FL, 4TREND Community, Philadelphia, PA, 5Horizon Therapeutics, Dublin, Ireland, 6Horizon Therapeutics, Deerfield, IL, 7Horizon Therapeutics, Cambridge, MA, 8Global Healthy Living Foundation, Nyack, NY

Meeting: ACR Convergence 2023

Keywords: Education, IgG4 Related Disease, Social support

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2089–2094) Patient Education/Community Service – Interprofessional Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Immunogobulin G4-Related Disease (IgG4-RD) is a rare chronic immune-mediated fibroinflammatory disorder that often manifests with tumor-like masses and/or enlargement of multiple organs. In order to guide future communications for people living with IgG4-RD, our objective was to examine the emotions expressed in social media discussions regarding IgG4-RD.

Methods: Data from YouTube and Reddit conversations from January 2017 to March 2023 were accessed using R packagestuber, for YouTube, and RedditExtractoR, for Reddit. The top viewed YouTube videos and their comments were searched using the terms “IgG4-RD” or “IgG4-Related Disease”. Resulting words from the video comments were used for sentiment analysis. Because IgG4-RD does not have its own subreddit,the subreddit r/Autoimmune was used for the Reddit analysis. We applied the same search terms to the top eight most commented subreddit threads for the analysis because these were the only IgG4-RD-related posts with comments. Data were separated into two groups: posts and comments on posts. Text was analyzed by classifying words within the Emotional Dynamic Classification System (EmoLex). Each word was assigned a positive or negative sentiment; each sentiment has four exclusive possible emotions associated with them. Depending on the sentiment, the word was assigned one to four negative or positive emotions. Only words with strong associations according to the EmoLex’s Association Score were included.

Results: Comments from seven YouTube videos, all created by or featuring physicians, were included in the analysis, with a total of 314 words analyzed. Fifty-three (165/314) words from comments had a positive sentiment (Table 1). Trust (37%) was the emotion most frequently associated with the text, followed by sadness (27%), anticipation (25%), fear (25%) and joy (20%). Advice and intelligence were words used evoking trust in the comments. Pain and hopeful evoked the emotions sadness and anticipation in the comments, respectively (Table 1). For Reddit, eight posts and their comments were included in the analysis. Posts had a total of 753 words and comments had 585 words. Posters to the subreddit were either recently diagnosed with IgG4-RD or seeking information on getting a diagnosis. Seventy-one percent (532/753) of words in these posts expressed negative sentiment (Table 2a). The top negative emotions for posts were sadness (42%), fear (34%), and disgust (21%) based on words like discomfort and anxiety (Table 2a). Trust was the only positive emotion associated with more than a fifth of the words (22%). Aggregated comment emotions were similar to those of YouTube comments, with trust as the most frequently associated emotion (42%), followed by anticipation (31%), sadness (28%), and fear (27%) (Table 2b).

Conclusion: Social media discussions of IgG4-RD provide insight into the patient experience. People living with IgG4-RD may benefit from patient-centered educational and supportive resources that focus on trust of health care providers and address negative emotions associated with the disease journey.

Supporting image 1

Table 1: Text Analysis Results of Aggregated YouTube Comments (N=314 words)

Supporting image 2

Table 2a: Text Analysis Results of Aggregated Reddit Posts (N=753 words)

Supporting image 3

Table 2b: Text Analysis Results of Aggregated Reddit Comments (N=585 words)


Disclosures: E. Rivera: Global Healthy Living Foundation, 3; K. Gavigan: Global Healthy Living Foundation, 3; D. Hernandez: Global Healthy Living Foundation, 3; M. Picone: TREND Community, 3, 12, Shareholder; A. Cordova: None; L. Dougherty: None; K. Davidson: Horizon Therapeutics, 3, 12, Stockholder; B. LaMoreaux: Horizon Therapeutics, 3, 12, Stockholder; A. Amatucci: Horizon Therapeutics, 3, 11; W. Nowell: AbbVie/Abbott, 2, 5, Amgen, 5, Janssen, 2, 5, Scipher Medicine, 5.

To cite this abstract in AMA style:

Rivera E, Gavigan K, Hernandez D, Picone M, Cordova A, Dougherty L, Davidson K, LaMoreaux B, Amatucci A, Nowell W. Social Listening Analysis of IgG4-Related Disease Social Media Discussions [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/social-listening-analysis-of-igg4-related-disease-social-media-discussions/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/social-listening-analysis-of-igg4-related-disease-social-media-discussions/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology